Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Baird Medical Investment Warrant -28 (BDMDW:NASDAQ), powered by AI.
Baird Medical Investment Warrant -28 is currently trading at $0.05. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Baird Medical Investment Warrant -28 on Alpha Lenz.
View Baird Medical Investment Warrant -28's valuation metrics on Alpha Lenz.
“Baird Medical Investment Warrant -28's ROE is -76.8%. Explore profitability and growth together.”
Ask for details →Baird Medical Investment Warrant -28 is a financial derivative instrument that provides the holder with the right, but not the obligation, to purchase shares of Baird Medical at a predetermined price before the expiry date in 2028. Warrants like this one are typically issued by companies to raise capital and incentivize investment by offering a potential for future equity purchase at a favorable price. The Baird Medical Investment Warrant -28 plays a crucial role in the financial markets as it offers speculative and leveraging opportunities for investors looking to capitalize on the company's future growth without immediately investing in the equity. Moreover, it reflects investors' expectations of Baird Medical's performance and their perceived growth prospects in the healthcare and medical sectors. As such, the warrant serves both as a tool for hedging against stock price movements and as a means of expanding into new investments by engaging in market derivatives.
“Baird Medical Investment Warrant -28's ROE is -76.8%. Explore profitability and growth together.”
Ask for details →Baird Medical Investment Warrant -28 (ticker: BDMDW) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 143 employees.
The current price is $0.05 with a P/E ratio of -x and P/B of -x.
ROE is -76.81% and operating margin is -113.31%. Annual revenue is $23M.